Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
about
Pediatric liver transplantation: Personal perspectives on historical achievements and future challengesDe novo autoimmune hepatitis in liver transplant: State-of-the-art reviewImportance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational toleranceDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsTreating inborn errors of liver metabolism with stem cells: current clinical developmentJuvenile autoimmune hepatitis: Spectrum of the disease.Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance.Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?Clinical relevance of autoantibodies after pediatric liver transplantation.Autoimmune hepatitis in children: diagnosis, pathology and treatment.Histopathology of de novo autoimmune hepatitis.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.Liver transplantation and autoimmune liver diseases.Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children.The histological quantification of alpha-smooth muscle actin predicts future graft fibrosis in pediatric liver transplant recipients.Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1.Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.Autoimmune Hepatitis in the Liver Transplant Graft.De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.Development of autoantibodies after pediatric liver transplantation.Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation.Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.Long-term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients.Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders.Rethinking immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatch
P2860
Q26751539-CBCA03E1-2CC1-445C-A59B-569737DD5567Q26766082-6E066438-A513-4154-86B0-6BEACDC36508Q27026283-676ECBE4-48C7-4CCA-B174-0A1B339CD2B1Q28076505-301EEEB2-A484-4485-93CB-CB90A3A59DC3Q33870631-52498B9C-0B2E-4596-8225-2A5F0291862FQ33948215-C2B38314-CB07-4DCD-8D4E-B41101421574Q34661366-E64978FA-7CB9-4E76-8100-08B05C001CA3Q36807116-6CEF7BE6-1A92-465E-BF89-1790D8FEBB3EQ36815305-DC252D84-FE00-4617-8496-9C5475CEB5B7Q37754771-2B92E93F-D5A9-43A8-811D-FAEDC1F456EBQ37989409-578C534F-A951-4FDB-B058-A2FDE41903BFQ38007886-EE02CEBC-A760-4C0E-B002-D53D1A408132Q38123133-DD0822E4-C2A6-4E3A-8AFF-CD08617B8D5FQ38403017-8DF8354A-3BEC-474B-A579-DD462AB2D123Q38806808-876A9C63-387A-44B5-859A-5CE70FE5BF9BQ38852645-BEC6E7AA-0580-41F9-895A-24B755CD41EFQ38973707-1F31CDC7-20ED-423D-9851-B4BC4276C28CQ39001834-4AC56B2E-9B35-4CF7-9CCE-225D07AD5A2DQ39212663-3975C159-A0B3-451D-8ABA-2E9530FA0426Q39818929-835787D8-B1EC-4353-9198-7165DA010DF3Q44715107-08AC926B-5A7D-4156-97A3-057F343C3686Q45045579-C9945D15-FECB-48EB-9C32-DDB23C839E55Q46390308-2C221A79-570F-435E-83E4-ACD39528847DQ51331002-6EA208E1-38F7-42E4-81F8-DA45A68682BAQ53259695-D7E597F3-522F-41D1-853E-9ABADBF19E00Q55318005-DE5F81C6-9C68-4FBD-9D03-D0CC67F0FEF1Q58798093-F0B255E3-71EF-4988-A080-E3158BDC8B19
P2860
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@en
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@nl
type
label
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@en
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@nl
prefLabel
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@en
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@nl
P2093
P1433
P1476
Posttransplant immune hepatiti ...... nce therapy with azathioprine.
@en
P2093
Bernard Otte J
Casamayou L
P304
P356
10.1097/00007890-200107270-00018
P577
2001-07-01T00:00:00Z